PCM
MSTR icon

Patient Capital Management’s Strategy Inc MSTR Stock Holding History

Patient Capital Management’s Portfolio MSTR Stock Details MSTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,092
Closed -$674K – 43
2025
Q3 		$674K Buy
+2,092
New +$776K 0.03% 40

Other funds holding MSTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Patient Capital Management's MSTR Position: Q4 2025 in Review

Patient Capital Management sold out of Strategy Inc (MSTR) in Q4 2025, closing a stake of 2,092 shares — an estimated $674K sold.

Patient Capital Management first reported a position in MSTR in Q3 2025 and held it in 1 quarter. The position peaked at $674K in Q3 2025. 979 funds tracked by Wall St. Rank hold MSTR as of Q4 2025.

  • Patient Capital Management reported no remaining Strategy Inc position as of Q4 2025 after selling out during the quarter.
  • Patient Capital Management sold 2,092 Strategy Inc shares in Q4 2025, an estimated $674K.
  • Patient Capital Management first reported a position in Strategy Inc in Q3 2025 and held it in 1 quarter.
  • Patient Capital Management's Strategy Inc position peaked at $674K in Q3 2025.
  • 979 funds tracked by Wall St. Rank held Strategy Inc as of Q4 2025.

Based on Patient Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.